Canada markets close in 5 hours 20 minutes

Quest PharmaTech Inc. (QPT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.02500.0000 (0.00%)
As of 03:12PM EDT. Market open.

Quest PharmaTech Inc.

4342 - 97 street NW
Edmonton, AB T6E 5R9
Canada
780-448-1400
https://www.questpharmatech.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Ragupathy Madiyalakan Ph.D.CEO & Director215kN/AN/A
Mr. Pierre Vermette C.A., CPAChief Financial Officer74.17kN/AN/A
Mr. Roger AndrewsHead of Investor Relations & Corporate CommunicationsN/AN/AN/A
Mr. Douglas C. BachmanVice President of Corporate Development37.94kN/A1954
Mr. Thomas WooVice President of Product DevelopmentN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Corporate Governance

Quest PharmaTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.